news Two COVID-19 vaccines show safety and strong immunity in infant model 16 June 2021 | By Victoria Rees (Drug Target Review) Two groups of infant rhesus macaques received one of two potential COVID-19 vaccines, which were shown to elicit high levels of neutralising antibodies.
article Challenges and opportunities in gene therapy development 7 June 2021 | By Dr Carsten Brunn (Selecta Biosciences) Despite the promise of gene therapies, significant challenges have emerged in the field. Dr Carsten Brunn discusses the current obstacles and opportunities when developing gene therapies.
news Tiny implant cures diabetes in mice without triggering immune response 7 June 2021 | By Victoria Rees (Drug Target Review) Scientists have developed an implant that releases insulin-secreting cells which has shown success at treating diabetes in mice.
news Broadly neutralising antibodies could form basis of influenza vaccine 4 June 2021 | By Victoria Rees (Drug Target Review) Antibodies produced by B cells against the H1N1 influenza virus can also neutralise other strains, which could be used to developed vaccines.
whitepaper ebook: How automation makes labs more efficient 4 June 2021 | By SPT Labtech We discuss how liquid handling automation supports drug discovery workflows & highlight opportunities to improve the efficiency and quality of these.
news Researchers identify how to potentially prevent cancer metastases 3 June 2021 | By Victoria Rees (Drug Target Review) Scientists have discovered that hepatic stellate cells are key in allowing dormant cancer cells to awaken and form fatal metastases.
whitepaper Application note: Western blot & IP assay to verify antibody specificity 1 June 2021 | By Bethyl Laboratories Learn about a practical, high-throughput method for validating the target-specificity of antibodies for the application of western blot.
news Novel DNA vaccine for SARS-CoV-2 effective in rodent models 1 June 2021 | By Victoria Rees (Drug Target Review) A new DNA vaccine encoding the SARS-CoV-2 Spike protein has shown promise at protecting mice and hamsters against COVID-19.
news Cross-reactive antibody could form basis of broad coronavirus vaccine 28 May 2021 | By Victoria Rees (Drug Target Review) Researchers have discovered a cross-reactive coronavirus antibody that could aid in the development of a broad-acting vaccine or treatment.
news Inhaled nanobodies effective against SARS-CoV-2 in hamsters 27 May 2021 | By Victoria Rees (Drug Target Review) Researchers have shown that inhalable nanobodies at ultra-low doses can effectively neutralise SARS-CoV-2 in hamsters.
whitepaper Brochure: Immuno-Oncology Solutions 26 May 2021 | By PerkinElmer A wide range of tools to support your immuno-oncology research and help redefine and develop tailored, life-changing immunotherapies to fight cancer.
news Asthma vaccine shows success in pre-clinical studies 18 May 2021 | By Victoria Rees (Drug Target Review) A new conjugate vaccine has shown promise at protecting mice against the effects of cytokines associated with asthma.
news New mouse model could be used to develop better HIV treatments 17 May 2021 | By Victoria Rees (Drug Target Review) A new pre-clinical mouse model could enable the study of HIV infection and the testing of cell therapies against the virus.
news Natural killer cells and bispecific antibody target lymphoma tumours 14 May 2021 | By Victoria Rees (Drug Target Review) In pre-clinical studies, researchers showed that cord blood-derived natural killer cells and a bispecific antibody eliminated lymphoma cells.
whitepaper Catalogue: Cytokines and growth factors from Sino Biological 13 May 2021 | By Sino Biological Inc. Sino Biological has developed 1,000+ cytokines and receptors, including growth factors, cytokines, chemokines, interferons, interleukins, etc.
